ABOS (Atlas Biologique de l'Obésité Sévère) - Influence of the Glycemic and Ponderal Status on Tissues Gene Expression (Biological Tissue Collection)

Head :
Pattou François, INSERM U859

Last update : 07/23/2015 | Version : 2 | ID : 5682

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Influence of the Glycemic and Ponderal Status on Tissues Gene Expression (Biological Tissue Collection)
Sign or acronym ABOS (Atlas Biologique de l'Obésité Sévère)
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CPP 06/49, DGS 2006/0307
General Aspects
Medical area Endocrinology and metabolism
Health determinants Genetic
Nutrition
Keywords diabetis, bariatric surgery, obesity
Scientific investigator(s) (Contact)
Name of the director Pattou
Surname François
Address 1 Place Verdun
Phone + 33 (0)3 20 44 42 73
Email fpattou@univ-lille2.fr
Unit INSERM U859
Organization CHRU
Collaborations
Participation in projects, networks and consortia Yes
Details Programme IT-DiabProgramme IMI-DIRECT
Funding
Funding status Mixed
Details CHRU LilleVaiomerIMI - Innovative Medicines Initiative / DIRECT - Diabetes Research on Patient Stratification
Governance of the database
Sponsor(s) or organisation(s) responsible CHRU Lille
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Longitudinal study (except cohorts)
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study Yes
Details Performed at individual level
Additional information regarding sample selection. Liver samples before and at 1 and 5 years after bariatric surgeryMuscle samples before and at 1 year after bariatric surgerySubcutaneous fat samples before and at 3 month and 1 year after bariatric surgeryVisceral fat samples in the great omentum before bariatric surgeryIntestinal samples during gastric by-pass surgeryBlood samples baseline and at at 1, 3 months, 1, 2, 5 years after surgery
Database objective
Main objective The objective of this trial is to study the influence of phenotypic characteristics on gene expression of tissues involved in glucose or/and lipidic metabolism with the creation of a collection of biological samples for research on obesity and diabetes.
Inclusion criteria • Age between 18 and 65 years.
• Indication of abdominal surgery requiring laparotomy or coelioscopy for obesity surgery, a cholecystectomy, or a parietal surgery.
• phenotype corresponding to one of the following four cases
1. BMI greater than or equal to 35 kg/m2 and diabetes defined by glucose greater or equal to 7 mmol/l fasting and/or greater than or equal to 11.1 mmol/l, 120 min after glucose intake (OGTT).
2. BMI greater than or equal to 35 kg/m2 and IGT defined by a higher than 6 mmol/l and less than 7 mmol/l fasting blood glucose, and/or greater than 7.8 mmol/l and less than 11.1 mmol/l, 120 min after glucose intake (OGTT).
3. BMI greater than or equal to 35 kg/m2 and with normal glucose tolerance defined by a blood glucose of less than or equal to 6 mmol/l and/or less than or equal to 7.8 mmol/l, 120 min after glucose intake (OGTT).
4. BMI inferior to 27 kg/m2 and with normal glucose tolerance defined by a blood glucose of less than or equal to 6 mmol/l and/or less than or equal to 7.8 mmol/l, 120 min after glucose intake (OGTT) (control group).
5. BMI between 27 and 35 27 kg/m2 and with normal glucose tolerance defined by a blood glucose less than or equal to 6 mmol/l and/or less than or equal to 7.8 mmol/l, 120 min after glucose intake (OGTT) (control group).
Population type
Age Childhood (6 to 13 years)
Adolescence (13 to 18 years)
Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Population covered General population
Gender Male
Woman
Geography area National
Detail of the geography area France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 06/2006
Size of the database
Size of the database (number of individuals) [500-1000[ individuals
Details of the number of individuals 850
Data
Database activity Current data collection
Type of data collected Clinical data
Declarative data
Biological data
Clinical data (detail) Direct physical measures
Medical registration
Details of collected clinical data Prospective assessment of clinical features before and after bariatric surgery: weight, BMI, blood pressure
Declarative data (detail) Paper self-questionnaire
Face to face interview
Phone interview
Details of collected declarative data Prospective assessment of clinical features before and after bariatric surgery: weight, BMI, blood pressure
Biological data (detail) Prospective assessment of biological features before and after bariatric surgery: alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), prothrombin time, platelets, serum triglyceride, cholesterolemia, fasting blood glucose, fasting insulin, blood glucose and insulin 120 minutes after ingestion of glucose (oral glucose tolerance test)
Presence of a biobank Yes
Contents of biobank Whole blood
Serum
Plasma
Blood cells isolated
Tissues
DNA
Details of biobank content Liver samples before and at 1 and 5 years after bariatric surgeryMuscle samples before and at 1 year after bariatric surgerySubcutaneous fat samples before and at 3 month and 1 year after bariatric surgeryVisceral fat samples in the great omentum before bariatric surgeryIntestinal samples during gastric by-pass surgeryBlood samples baseline and at at 1, 3 months, 1, 2, 5 years after surgery
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method before and after bariatric surgery
Quality procedure(s) used monitoring promoteur
Participant monitoring Yes
Details on monitoring of participants Prospective assessment of clinical and biological features before and after bariatric surgeryLiver samples before and at 1 and 5 years after bariatric surgeryMuscle samples before and at 1 year after bariatric surgerySubcutaneous fat samples before and at 3 month and 1 year after bariatric surgeryVisceral fat samples in the great omentum before bariatric surgeryIntestinal samples during gastric by-pass surgeryBlood samples baseline and at at 1, 3 months, 1, 2, 5 years after surgery
Links to administrative sources Yes
Promotion and access
Promotion
Link to the document http://tinyurl.com/Hal-ABOS
Description Liste des publications dans HAL
Link to the document http://tinyurl.com/Pubmed-ABOS
Description Liste des publications dans Pubmed
Access
Terms of data access (charter for data provision, format of data, availability delay) Contact the investigator
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here